Test for C3 nephritic factor activity by immunofixation electrophoresis.

Area of Science:

• Nephrology
• Immunology
• Clinical Chemistry

Background:

• C3 nephritic factor (C3NeF) is an autoantibody implicated in certain kidney diseases.
• Accurate detection of C3NeF activity is crucial for diagnosing conditions like basement membrane dense deposit disease (BMDDD).
• Existing diagnostic methods may be complex or lack sensitivity.

Purpose of the Study:

• To develop and validate a simple, reliable assay for quantifying C3NeF activity.
• To assess the utility of the assay in differentiating BMDDD from other renal diseases.

Main Methods:

• Development of a novel assay using immunofixation electrophoresis.
• Quantitation of C3c, a breakdown product of C3, as a marker of C3NeF activity.
• Testing on plasma samples from healthy controls, patients with various renal diseases, and patients with BMDDD.

Main Results:

• The developed assay demonstrated high specificity, yielding negative results in 22 controls and 93 patients with non-BMDDD renal diseases.
• Plasma samples from three patients with biopsy-confirmed BMDDD were positive for C3NeF activity.
• C3NeF activity levels in BMDDD patients were significantly elevated compared to control and other renal disease groups.
• The assay is compatible with EDTA-treated specimens, allowing for stable sample storage and transport at ambient temperatures.

Conclusions:

• The immunofixation electrophoresis-based assay is a simple and effective method for detecting C3NeF activity.
• This test can aid in the diagnosis of basement membrane dense deposit disease.
• The assay's robustness allows for practical application in clinical settings.